Kristensen, Jesper B.; Pedersen, Mette L.; Larsen, Ulla D.; Martiny, Lars; Hansen, Louis B.; Foged, Christian
doi: 10.1002/jlcr.689pmid: N/A
Arg34Lys26(Nε‐(γ‐L‐glutamyl(Nα‐palmitoyl)))‐GLP‐1(7‐37) (NN2211) is currently in development as a diabetes type 2 drug. The fatty acid attached to the GLP‐1(7‐37) ensures a long and controlled duration of action. The synthesis of (125I)NN2211, (127I)NN2211 and (14C)NN2211 used for preclinical ADME studies are described. NN2211 was iodinated using the lactoperoxidase/hydrogen peroxide method, and (14C)NN2211 was synthesized in 4 steps by two routes both starting from an α‐protected (U‐14C)glutamic acid. Copyright © 2003 John Wiley & Sons, Ltd.